Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.
Level 5 - mechanism / opinion, no new human data
In vitro bench study with synthetic peptides (mechanism-based reasoning)
PubMed 10936205 · doi:10.1046/j.1471-4159.2000.0751219.x
What was done
The authors developed a competitive metal capture analysis using metal-chelator complexes to determine the stoichiometries, binding affinities, and cooperativity of Cu(2+) binding to synthetic Abeta1-40 and Abeta1-42. They also evaluated the solubility of Abeta peptide (10 microM) over 5 days in the presence of high-affinity Cu(2+)-selective chelators.
What was found
Abeta1-42 exhibited a very-high-affinity Cu(2+)-binding site with log K(app) = 17.2, which mediated peptide precipitation in the presence of trace Cu(2+) contamination (customarily approximately 0.1 microM). In contrast, Abeta1-40 had a lower affinity at this site (estimated log K(app) = 10.3) and greater negative cooperativity. Abeta peptide (10 microM) remained soluble for 5 days only when high-affinity Cu(2+)-selective chelators were present.
Why it matters
These findings identify a biochemical mechanism explaining why Abeta1-42 aggregates more readily than Abeta1-40, demonstrating that trace copper contamination can drive amyloid precipitation.
Limits
This was an entirely in vitro study using synthetic peptides, and the abstract does not report sample sizes, replicate numbers, or in vivo biological validation in human tissue.
Cited by
- supports Research by Ashley Bush showed that amyloid-beta binds divalent metals including copper, zinc, and iron.